المؤلفون: Federica Giannotti, Carmen De Ramon Ortiz, Federico Simonetta, Sarah Morin, Chiara Bernardi, Stavroula Masouridi-Levrat, Yves Chalandon, Anne-Claire Mamez

المصدر: Frontiers in Immunology, Vol 15 (2024)

مصطلحات موضوعية: Hodgkin lymphoma, pembrolizumab, brentuximab-vedotin, haploidentical allogeneic stem cell transplant, DLI, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1360275/full; https://doaj.org/toc/1664-3224

URL الوصول: https://doaj.org/article/cbfb749dbff44cd88f3e883f56499b63

المؤلفون: Giannotti, Federica, De Ramon Ortiz, Carmen Julia, Simonetta, Federico, Morin, Sarah, Bernardi, Chiara, Masouridi Levrat, Stavroula, Chalandon, Yves, Mamez, Anne-Claire

المصدر: ISSN: 1664-3224 ; Frontiers in immunology, vol. 15 (2024) 1360275.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, DLI, Hodgkin lymphoma, Brentuximab-vedotin, Haploidentical allogeneic stem cell transplant, Pembrolizumab, Humans, Brentuximab Vedotin / therapeutic use, Hodgkin Disease / drug therapy, Programmed Cell Death 1 Receptor, Neoplasm Recurrence, Local / drug therapy, Hematopoietic Stem Cell Transplantation / adverse effects, Graft vs Host Disease / etiology, Graft vs Host Disease / drug therapy, Antibodies, Monoclonal, Humanized

Relation: info:eu-repo/semantics/altIdentifier/pmid/38510239; https://archive-ouverte.unige.ch/unige:179761; unige:179761

الاتاحة: https://archive-ouverte.unige.ch/unige:179761